Effect of Lysyl Oxidase G473 A Polymorphism on Lysyl Oxidase and Total Soluble Collagen Expression in Oral Submucous Fibrosis.
Autor: | Mukherjee S; CSIR-Indian Institute of Chemical Biology, Kolkata, India., Katarkar A; CSIR-Indian Institute of Chemical Biology, Kolkata, India., Dhariwal R; Department of Oral Pathology, Dr. R. Ahmed Dental College and Hospital, Kolkata, India., Mohanty S; Department of Oral Pathology, Dr. R. Ahmed Dental College and Hospital, Kolkata, India., Mahato B; Department of Oral Pathology, Dr. R. Ahmed Dental College and Hospital, Kolkata, India., Ray JG; Department of Oral Pathology, Dr. R. Ahmed Dental College and Hospital, Kolkata, India., Chaudhuri K; CSIR-Indian Institute of Chemical Biology, Kolkata, India. |
---|---|
Jazyk: | angličtina |
Zdroj: | Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2021 Aug 01; Vol. 22 (8), pp. 2493-2499. Date of Electronic Publication: 2021 Aug 01. |
DOI: | 10.31557/APJCP.2021.22.8.2493 |
Abstrakt: | Background: Oral submucous fibrosis (OSF) is a debilitating collagen-metabolic disorder leading to submucosal fibrosis and trismus. Lysyl oxidase (LOX), a critical collagen biosynthetic enzyme, is up-regulated in OSF. Polymorphisms in the Lysyl oxidase gene have been associated with increased risk of OSF and might affect normal collagen synthesis, accumulation, or degradation, crucial in determining fibrosis severity. Methods: One hundred OSF cases and 100 controls were genotyped for LOX G473A(Arg158Gln) polymorphism by polymerase chain reaction-restriction fragment length polymorphism. The expression of LOX was estimated both by quantitative mRNA analysis and western blot. Total soluble collagen was evaluated from mucosal tissue obtained from OSF cases. Immunohistochemical (IHC) localization of type 1 collagen was performed in mucosal tissue obtained from patients carrying various genotypes. Results: Heterozygous G473A genotype was significantly higher in OSF cases [2.063(95% CI =1.059-4.016)], among 26-40 years age-group [4.375(95% CI=1.323-14.267),p=0.029] and in male patients [2.38 (95% CI= 1.107-5.121), p= 0.042]. LOX expression was significantly higher in cases of the heterozygous or homozygous carrier (p <0.001). We found the total soluble collagen level significantly (p <0.001) higher among patients carrying GA or AA genotype. IHC revealed focal deposition of type1 collagen in the submucosal tissue; comparatively higher deposition was evident in mucosal tissue of OSF patients carrying AA genotype. Conclusions: These findings suggest LOX G473A polymorphism confers an increased risk of OSF and may affect collagen accumulation in OSF cases. |
Databáze: | MEDLINE |
Externí odkaz: |